Souhaitez-vous accéder aux communiqués récents ?

First Steps Developmental Services launches two new ABA programs in Woburn, MA — no waitlist for children with Autism ages 0–6.

Bike to the Beach for Autism DMV, Friday, June 19, 2026 - Raising funds for LOCAL autism & disability nonprofits

Marvel Biosciences Corp. announces it has identified two lead pediatric-friendly liquid formulations of its patented lead compound, MB-204.

Unyte Health acquires Vital Links and Vital Sounds, enhancing its suite of powerful listening therapies for clinicians and healthcare providers.

Marvel announces financial and strategic backing from 5 Horizons Ventures to support its upcoming Phase 1 clinical trial of patented lead asset MB-204

Lighthouse Autism Center is Opening in Rocky Mount, North Carolina in June 2026

Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I clinical trials of its autism-focused patented MB-204

Lighthouse Autism Center is Opening in Asheboro, North Carolina this August

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist

Peer-reviewed publication validates the potential of Itay&Beyond's human CNS platform for advanced disease stratification, translational research, and R&D